arrow
C

Colin C. Pritchard

university of washington
H指数:60
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Interference of clonal hematopoiesis in cfDNA liquid biopsy testing and identification of actionable alterations in large diverse cohort of US veterans

克隆性造血对cfDNA液体活检检测的干扰及在美国退伍军人大型多样化队列中可操作变异的识别

2026-07-210
OAAI
Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiology

多组学评估揭示了LNCaP及其衍生细胞系在前列腺癌病理生物学中的决定因素

2025-11-170
OA
Results from a Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in the Treatment of Patients with Metastatic Castration-resistant Prostate Cancer with DNA Homologous Recombination Repair Deficiency

多西他赛和卡铂诱导治疗伴DNA同源重组修复缺陷的转移性去势抵抗性前列腺癌患者的2期研究结果

2025-05-230
PRE
Preeclampsia risk prediction from prenatal cell-free DNA screening

从产前游离DNA筛查中预测子痫前期的风险

2025-02-122
OA
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers
2023-05-014
PRE
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

晚期前列腺癌-转移性和/或去势抵抗性前列腺癌患者的管理: 晚期前列腺癌共识会议 (APCCC) 2022的报告

2023-05-0166
OA
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

晚期前列腺癌患者的管理。第一部分: 中/高危和局部晚期疾病,生化复发和激素治疗的副作用: 晚期前列腺癌共识会议2022的报告

2023-03-0164
OA
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer

1671晚期胆道癌患者游离DNA改变的临床表现

2022-12-0165
OA
Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes
2022-11-1826
OAAI
Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021

晚期前列腺癌患者的管理: 2021晚期前列腺癌共识会议的报告

2022-07-0165
OA
Profiling PI3K-AKT-MTOR variants in focal brain malformations reveals new insights for diagnostic care
BRAIN
IF11.7
2022-03-3133
OA
Genomic attributes of homology-directed DNA repair deficiency in metastatic prostate cancer
2021-12-0815
OA
PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer
2021-08-0623
OAAI
Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer
2021-04-0143
OAAI
Germline variants drive myelodysplastic syndrome in young adults

种系变异导致年轻人的骨髓增生异常综合征

LEUKEMIA
IF13.4
2021-01-2847
OA
Clinical impact of somatic alterations in prostate cancer patients with and without previously known germline BRCA1/2 mutations: Results from PROREPAIR-A study
2020-09-015
PREAI